Cargando…

Clostridioides difficile infection in patients with nonalcoholic fatty liver disease-current status

Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease, leading to fibrosis, cirrhosis and hepatocellular carcinoma and also associated with increased cardiovascular disease mortality. The pathogenesis of NAFLD is not fully understood, although NAFLD is thought to be a hep...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kiseleva, Yana V, Maslennikov, Roman V, Gadzhiakhmedova, Aida N, Zharikova, Tatyana S, Kalinin, Dmitry V, Zharikov, Yury O
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2023
Materias:	Minireviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10011916/ https://www.ncbi.nlm.nih.gov/pubmed/36926243 http://dx.doi.org/10.4254/wjh.v15.i2.208

Ejemplares similares

Molecular pathways of liver regeneration: A comprehensive review
por: Kiseleva, Yana V, et al.
Publicado: (2021)

Comments on “Relationship between body composition and PBRM1 mutations in clear cell renal cell carcinoma: a propensity score matching analysis”
por: Pontes-Silva, André, et al.
Publicado: (2023)

Identifying sex-specific injury predictors as a key factor in maintaining optimal physical activity levels
por: Sankova, Maria V, et al.
Publicado: (2023)

Clostridioides difficile infection and One Health: an equine perspective
por: Hain‐Saunders, Natasza M.R., et al.
Publicado: (2022)

Impact of Primary and Secondary Bile Acids on Clostridioides Difficile Infection
por: Łukawska, Agata, et al.
Publicado: (2022)

Immunological mechanisms of fecal microbiota transplantation in recurrent Clostridioides difficile infection
por: Soveral, Lucas F, et al.
Publicado: (2022)

Rare primary mature teratoma of the liver: A case report
por: Kovalenko, Yury A, et al.
Publicado: (2021)

Hepatocellular carcinoma in nonalcoholic fatty liver disease: A growing challenge
por: Mattos, Ângelo Z, et al.
Publicado: (2021)

Mediterranean diet and nonalcoholic fatty liver disease
por: Anania, Caterina, et al.
Publicado: (2018)

Risk factors and diagnostic biomarkers for nonalcoholic fatty liver disease-associated hepatocellular carcinoma: Current evidence and future perspectives
por: Ueno, Masayuki, et al.
Publicado: (2022)

Associations between nonalcoholic fatty liver disease and ischemic stroke
por: Alkagiet, Stelina, et al.
Publicado: (2018)

Multiomics biomarkers for the prediction of nonalcoholic fatty liver disease severity
por: Pirola, Carlos J, et al.
Publicado: (2018)

Advances in paediatric nonalcoholic fatty liver disease: Role of lipidomics
por: Di Sessa, Anna, et al.
Publicado: (2021)

Emerging role of engineered exosomes in nonalcoholic fatty liver disease
por: Ding, Jian, et al.
Publicado: (2023)

Nonalcoholic fatty liver disease and COVID-19: An epidemic that begets pandemic
por: Ahmed, Musaab, et al.
Publicado: (2021)

Anatomical basis for pancreas transplantation via isolated splenic artery perfusion: A literature review
por: Dmitriev, Ilya, et al.
Publicado: (2022)

Nonalcoholic Fatty Liver Disease—A Novel Risk Factor for Recurrent Clostridioides difficile Infection
por: Šamadan, Lara, et al.
Publicado: (2021)

Th17 involvement in nonalcoholic fatty liver disease progression to non-alcoholic steatohepatitis
por: Chackelevicius, Carla Melisa, et al.
Publicado: (2016)

Intestinal microbiota participates in nonalcoholic fatty liver disease progression by affecting intestinal homeostasis
por: Zhang, Yang, et al.
Publicado: (2021)

Nonalcoholic fatty liver disease is associated with worse intestinal complications in patients hospitalized for Clostridioides difficile infection
por: Jiang, Yi, et al.
Publicado: (2021)

Clostridioides difficile co-infection in patients with COVID-19
por: Maslennikov, Roman, et al.
Publicado: (2022)

Pleiotropy within gene variants associated with nonalcoholic fatty liver disease and traits of the hematopoietic system
por: Pirola, Carlos Jose, et al.
Publicado: (2021)

Role of vascular endothelial growth factor B in nonalcoholic fatty liver disease and its potential value
por: Li, Yu-Qi, et al.
Publicado: (2023)

Editorial: Microbial interactions of Clostridioides difficile
por: Goh, Shan, et al.
Publicado: (2023)

The Current Knowledge on Clostridioides difficile Infection in Patients with Inflammatory Bowel Diseases
por: Boeriu, Alina, et al.
Publicado: (2022)

Improving nutrition for the prevention of gestational diabetes: Current status and perspectives
por: Popova, Polina V, et al.
Publicado: (2021)

Risk modeling of femoral neck fracture based on geometric parameters of the proximal epiphysis
por: Shitova, Anna D, et al.
Publicado: (2022)

Clinical indicators for progression of nonalcoholic steatohepatitis to cirrhosis
por: Seen, Tasur Kumar, et al.
Publicado: (2021)

Non-clostridium difficile induced pseudomembranous colitis
por: Jagirdhar, Gowthami Sai Kogilathota, et al.
Publicado: (2023)

Role of osteoprotegerin/receptor activator of nuclear factor kappa B/receptor activator of nuclear factor kappa B ligand axis in nonalcoholic fatty liver disease
por: Pacifico, Lucia, et al.
Publicado: (2018)

Marine polyunsaturated fatty acids and cancer therapy
por: Vaughan, V C, et al.
Publicado: (2013)

An in silico survey of Clostridioides difficile extrachromosomal elements
por: Hornung, Bastian V. H., et al.
Publicado: (2019)

Diagnostic Methods of Clostridioides difficile Infection and Clostridioides difficile Ribotypes in Studied Sample
por: Novakova, Elena, et al.
Publicado: (2021)

Estimating the success of enzyme bioprospecting through metagenomics: current status and future trends
por: Ferrer, Manuel, et al.
Publicado: (2015)

Nationwide Survey for Current Status of Laboratory Diagnosis of Clostridioides difficile Infection in Korea
por: Chung, Hae-Sun, et al.
Publicado: (2022)

Characteristics of the Clostridium difficile cell envelope and its importance in therapeutics
por: Kirk, Joseph A., et al.
Publicado: (2016)

Clostridioides difficile infection in the Asia-Pacific region
por: Collins, Deirdre A., et al.
Publicado: (2019)

Current and emerging therapeutic strategies in pancreatic cancer: Challenges and opportunities
por: Manrai, Manish, et al.
Publicado: (2021)

Mouse models for investigating the underlying mechanisms of nonalcoholic steatohepatitis-derived hepatocellular carcinoma
por: Takakura, Kazuki, et al.
Publicado: (2018)

Current approaches to the management of patients with cirrhotic ascites
por: Garbuzenko, Dmitry Victorovich, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_jdc8pd0i03fmnnhnqkk8a0bnva